Symbiotec: Global API manufacturer, specializing in Cortico-Steroids & Steroid-Hormone APIs.
01 1Symbiotec Pharmalab Private Limited
02 1Aspen Oss B.V.
03 1AX Pharmaceutical Corp
04 1DARMERICA, LLC
05 2Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd.
06 1Professional Compounding Centers of America dba PCCA
07 1SUN PHARMACEUTICAL INDUSTRIES, INC.
08 1Steroid S.p.A.
01 117-Alpha-Hydroxyprogesterone
02 1HYDROXYPROGESTERONE CAPROATE
03 1Hydoxyprogesterone Caproate
04 5Hydroxyprogesterone Caproate
05 1Hydroxyprogesterone Caproate Micronized
01 1Canada
02 2China
03 2India
04 1Italy
05 1Netherlands
06 1U.S.A
07 1United Kingdom
NDC Package Code : 22552-0045
Start Marketing Date : 2016-03-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 60870-0408
Start Marketing Date : 1992-01-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 73377-174
Start Marketing Date : 2022-07-18
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 71052-200
Start Marketing Date : 2021-04-07
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 64025-0003
Start Marketing Date : 2009-12-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 64025-0018
Start Marketing Date : 2009-12-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-2733
Start Marketing Date : 1999-06-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 49803-001
Start Marketing Date : 2015-09-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25000g/25000g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62756-303
Start Marketing Date : 2020-05-12
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
A Hydroxyprogesterone Caproate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Hydroxyprogesterone Caproate, including repackagers and relabelers. The FDA regulates Hydroxyprogesterone Caproate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Hydroxyprogesterone Caproate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Hydroxyprogesterone Caproate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Hydroxyprogesterone Caproate supplier is an individual or a company that provides Hydroxyprogesterone Caproate active pharmaceutical ingredient (API) or Hydroxyprogesterone Caproate finished formulations upon request. The Hydroxyprogesterone Caproate suppliers may include Hydroxyprogesterone Caproate API manufacturers, exporters, distributors and traders.
click here to find a list of Hydroxyprogesterone Caproate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Hydroxyprogesterone Caproate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Hydroxyprogesterone Caproate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Hydroxyprogesterone Caproate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Hydroxyprogesterone Caproate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Hydroxyprogesterone Caproate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Hydroxyprogesterone Caproate suppliers with NDC on PharmaCompass.
We have 8 companies offering Hydroxyprogesterone Caproate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?